Bing Yao

Title: The Innovative Contributions of Bing Yao

Introduction

Bing Yao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic compounds. With a total of 2 patents, his work focuses on innovative solutions to complex medical challenges.

Latest Patents

Bing Yao's latest patents include groundbreaking inventions that target specific protein activities. One of his notable patents is for cyclic molecules as Bruton's tyrosine kinase inhibitors. This invention relates to a novel molecule with protein tyrosine kinase inhibitory activity, along with its synthesis and usage. The patent specifically details a compound by formula A, including pharmaceutically acceptable salts, hydrates, or solvates thereof. Another significant patent involves PRMT5 inhibitors and methods of use. This patent provides compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity, along with methods for their preparation and use. The compounds are described by Formula (I) and include pharmaceutically acceptable salts, hydrates, and solvates.

Career Highlights

Bing Yao is currently associated with Shanghai Apeiron Therapeutics Company Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective therapeutic solutions.

Collaborations

Bing Yao collaborates with esteemed colleagues in his field, including Xiaohui Gu and Zhaoyin Wang. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.

Conclusion

Bing Yao's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his role as a leading inventor. His work continues to pave the way for advancements in medical therapies.